Used as an intermediate in the synthesis of pharmaceutical compounds, particularly in the development of central nervous system (CNS) agents. Its structure supports the creation of bioactive molecules with potential antipsychotic, antidepressant, or anxiolytic properties. The trifluoromethylphenyl group enhances metabolic stability and membrane permeability, making it valuable in drug design. Commonly employed in medicinal chemistry for structure-activity relationship (SAR) studies to optimize potency and selectivity of new drug candidates.